SG11202111417UA - Electronic devices and methods for treatment of depressive symptoms, depressive disorders utilizing digital therapies - Google Patents
Electronic devices and methods for treatment of depressive symptoms, depressive disorders utilizing digital therapiesInfo
- Publication number
- SG11202111417UA SG11202111417UA SG11202111417UA SG11202111417UA SG11202111417UA SG 11202111417U A SG11202111417U A SG 11202111417UA SG 11202111417U A SG11202111417U A SG 11202111417UA SG 11202111417U A SG11202111417U A SG 11202111417UA SG 11202111417U A SG11202111417U A SG 11202111417UA
- Authority
- SG
- Singapore
- Prior art keywords
- depressive
- treatment
- methods
- electronic devices
- utilizing digital
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Social Psychology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Educational Technology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962835295P | 2019-04-17 | 2019-04-17 | |
| DKPA201970330A DK201970330A1 (en) | 2019-04-17 | 2019-05-24 | Electronic devices and methods for treatment of depressive symptoms, depressive disorders utilizing digital therapies |
| PCT/US2020/027892 WO2020214513A1 (en) | 2019-04-17 | 2020-04-13 | Electronic devices and methods for treatment of depressive symptoms, depressive disorders utilizing digital therapies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202111417UA true SG11202111417UA (en) | 2021-11-29 |
Family
ID=72830854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202111417UA SG11202111417UA (en) | 2019-04-17 | 2020-04-13 | Electronic devices and methods for treatment of depressive symptoms, depressive disorders utilizing digital therapies |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200335191A1 (en) |
| EP (1) | EP3956899A1 (en) |
| JP (1) | JP2022529474A (en) |
| KR (1) | KR20220011118A (en) |
| CN (1) | CN114303204A (en) |
| AU (1) | AU2023241396A1 (en) |
| IL (1) | IL286964A (en) |
| SG (1) | SG11202111417UA (en) |
| WO (1) | WO2020214513A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020096651A1 (en) * | 2018-11-07 | 2020-05-14 | Novartis Ag | Electronic devices and methods for treatment utilizing antipsychotics in combination with digital therapies |
| WO2021214553A1 (en) | 2020-04-24 | 2021-10-28 | The Joan and Irwin Jacobs Technion-Cornell Institute | Treating mental health disorders using machine learning |
| EP4143850A4 (en) | 2020-04-29 | 2023-10-18 | S-Alpha Therapeutics, Inc. | Antiviral digital device |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008310576B2 (en) * | 2007-10-12 | 2014-01-23 | Patientslikeme, Inc. | Personalized management and comparison of medical condition and outcome based on profiles of community of patients |
| CA2773330C (en) * | 2009-09-29 | 2021-11-02 | Novartis Ag | Dosage regimen of an s1p receptor modulator |
| US20110289443A1 (en) * | 2010-05-19 | 2011-11-24 | Workforceperformance Llp | Behavioral Training and Development |
| US8617067B2 (en) * | 2011-05-13 | 2013-12-31 | Fujitsu Limited | Continuous monitoring of stress using environmental data |
| EP2899686A4 (en) * | 2012-09-24 | 2016-11-23 | Nec Solution Innovators Ltd | Mental health care support device, system, method, and program |
| EP2923643A4 (en) * | 2012-11-21 | 2016-07-20 | Nec Solution Innovators Ltd | System for supporting correction of distorted cognition, method of eliciting user consciousness information and program therefor |
| WO2016004396A1 (en) * | 2014-07-02 | 2016-01-07 | Christopher Decharms | Technologies for brain exercise training |
| CN113892147A (en) * | 2019-04-17 | 2022-01-04 | 派尔疗法股份有限公司 | Electronic device and method for treating depressive symptoms associated with multiple sclerosis |
-
2020
- 2020-04-13 JP JP2021561931A patent/JP2022529474A/en active Pending
- 2020-04-13 SG SG11202111417UA patent/SG11202111417UA/en unknown
- 2020-04-13 KR KR1020217035660A patent/KR20220011118A/en unknown
- 2020-04-13 CN CN202080038801.0A patent/CN114303204A/en active Pending
- 2020-04-13 US US16/846,996 patent/US20200335191A1/en not_active Abandoned
- 2020-04-13 WO PCT/US2020/027892 patent/WO2020214513A1/en unknown
- 2020-04-13 EP EP20722200.1A patent/EP3956899A1/en not_active Withdrawn
-
2021
- 2021-10-04 IL IL286964A patent/IL286964A/en unknown
-
2023
- 2023-10-08 AU AU2023241396A patent/AU2023241396A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023241396A1 (en) | 2023-10-26 |
| IL286964A (en) | 2021-12-01 |
| KR20220011118A (en) | 2022-01-27 |
| CN114303204A (en) | 2022-04-08 |
| JP2022529474A (en) | 2022-06-22 |
| WO2020214513A1 (en) | 2020-10-22 |
| US20200335191A1 (en) | 2020-10-22 |
| EP3956899A1 (en) | 2022-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268349A (en) | Combination therapies for treatment of bcma-related cancers and autoimmune disorders | |
| IL286964A (en) | Electronic devices and methods for treatment of depressive symptoms, depressive disorders utilizing digital therapies | |
| IL259861A (en) | Methods and compositions for the treatment of seizure-related disorders | |
| IL286965A (en) | Electronic devices and methods for treating depressive symptoms associated with multiple sclerosis | |
| IL270781A (en) | Treatment of depressive disorders | |
| HK1248124A1 (en) | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders | |
| IL269604A (en) | Pantids for treatment of autoimmune disorders | |
| IL281736A (en) | Methods of treating myeloproliferative disorders | |
| SG11202104053TA (en) | Compositions and methods for the treatment of estrogen-dependent disorders | |
| IL275985A (en) | Compositions and methods for treating retinal disorders | |
| EP3258930A4 (en) | Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders | |
| IL292678A (en) | Methods of treating depressive disorders | |
| IL292186A (en) | Compositions and methods for treating blood disorders | |
| IL284029A (en) | Peptides for treatment and prevention of diabetes and associated disorders | |
| IL284117A (en) | Compositions, devices, and methods for the treatment of overdose and reward-based disorders | |
| EP3423049A4 (en) | Methods of treating or alleviating mental disorders and associated symptoms | |
| IL281589A (en) | Methods of treating myeloproliferative disorders | |
| EP3897601A4 (en) | Treatment of gastrointestinal disorders and symptoms thereof | |
| SG11202105279SA (en) | Methods of treating myeloproliferative disorders | |
| IL289734A (en) | Compositions and methods for the treatment of sanfilippo disease and other disorders | |
| SG11202007642RA (en) | Treatment of disorders with tasimelteon | |
| EP3773328C0 (en) | Poland syndrome and methods of treatment | |
| IL290983A (en) | Methods of treatment | |
| GB201918853D0 (en) | Methods of treatment | |
| GB201808723D0 (en) | Treatment of hyperproliferative disorders |